CJC-1295 (CJC-1295 with DAC, CAS 446262-90-4) is a synthetic peptide consisting of 30 amino acids, structurally modified based on human growth hormone-releasing hormone (GHRH). Its molecular weight is 3647.28 Da. The product appears as a white lyophilized powder, with HPLC purity ≥99%. Every batch comes with complete COA and HPLC test reports for quality verification.

Thanks to the DAC (Drug Affinity Complex) modification, CJC-1295 can reversibly bind to albumin in blood, greatly extending its circulation half-life for research use. It functions as a high-affinity agonist of the GHRH receptor. In preclinical studies, it is widely explored for its effects on endocrine modulation, growth hormone secretion, IGF-1 production, body composition and anabolic metabolism.